In 2026, payers like UnitedHealthcare and Optum are not using manual reviewers to deny your claims. They are using AI algorithms trained to spot a single missing Z-Code or a mismatched LOINC code in milliseconds. If you are fighting these algorithms with spreadsheets and phone calls, you have already lost. Dastify Solutions is the laboratory denial management service that fights AI with AI. We do not wait for the rejection letter. We use predictive risk scoring to audit your claims against millions of payer rules before they leave your LIS.
Our "Shift-Left" Prevention Strategy
Real-Time Eligibility and Auth
For high-cost tests, we automate the Prior Authorization process. We verify eligibility and benefits at the moment of accession, ensuring the patient actually has coverage for the specific panel ordered.
Tired of Fighting AI Denials With Manual Appeals?
When a denial does happen, we don’t send a form letter. We sent a forensic argument. Generic appeals get generic rejections. Our lab denial resolution team breaks down rejections by code and counter-attacks using RPA-enabled appeal submission.
We combine root cause, payer language, and our technical fix into one Technical Resolution Matrix
| Metric | The Payer's Argument | Our Solution |
|---|---|---|
| CO-50: Medical Necessity | "The diagnosis does not support this panel." | We pull the ordering provider's history and prior successes to prove longitudinal complexity capture. We attach the specific LCD article proving coverage. |
| CO-97: Bundling (CCI Edits) | "This test is included in another code." | We analyze NCCI Edits to identify if a 59 or X{EPSU} modifier is genuinely warranted. If the test is distinct, we fight for separate reimbursement. |
| CO-16: Info Missing | "Claim lacks information." | Usually a missing date of collection or referring to NPI. We pull the missing field directly from the LIS through the interface and resubmit inside 24 hours. |
In 2026, payers are increasingly using Internal Processing Edits that are not formal denials. No CARC code is issued, but the claim sits in “Pending” status indefinitely. This is the hidden “silent denial” that starves your cash flow.
We call this the “Black Hole” of pending claims.
We target this Black Hole using a dedicated Pending Claim Liquidation process. Our RPA bots continuously monitor payer portals for stalled claims and force a payer adjudication within 72 hours of submission. By driving a decision (pay or deny), we convert silent inventory into actionable revenue recovery and follow‑up.
We use Robotic Process Automation (RPA) to submit these appeals directly into payer portals. This bypasses the mailroom and puts your appeal in front of a reviewer days faster than manual submission.
The specific patient notes proving the test was vital for treatment.
We attach the exact Local Coverage Determination article that mandates coverage.
For genetic tests, we include clinical studies supporting the test's validity to counter "experimental" claims.
Your Medicare lab rates are set by the data your lab reports to CMS under PAMA. Congress keeps pushing the reporting window back. The latest delay came through the Consolidated Appropriations Act, 2026 and the SALSA bill that would fix this permanently still has not passed. That leaves labs planning around a deadline that moves. We pull and normalise your private payer payment data on an ongoing basis, so whenever the window opens, your file is ready and accurate instead of assembled in a panic. Under-reporting your commercial rates is what drags the fee schedule down. We make sure yours reflects what you actually get paid.
For out‑of‑network or cash‑pay patients, transparency is law. We automate Good Faith Estimates for self-pay and uninsured patients, which is enforceable today. The Advanced EOB requirement for insured patients is still in rulemaking and not being enforced, so we build your workflow to slot it in without a rebuild when the rule lands. This prevents patient disputes, reduces “surprise bill” litigation risk, and keeps you compliant with federal price transparency rules.
Payers use RAC (Recovery Audit Contractors) to claw back money years after payment. We analyze your historical data to find patterns that trigger these audits. We “audit‑proof” your documentation now so you are safe later.
We focus on MolDX, Z‑Codes, and establishing medical necessity for hereditary cancer and PGx panels. We explicitly manage combinatorial PGx logic, ensuring multi‑gene pharmacogenomic panels are billed as a single unit where required, maintaining unit‑level compliance with payer rules. We know how to fight the "genetic counseling not documented" denial.
We strictly monitor qualitative vs. quantitative frequency limits. We ensure your billing frequency matches the patient's risk profile to avoid "frequency exceeded" denials.
We manage the split between the Technical Component (TC) and the Professional Component (26). We ensure 88305 codes are utilized correctly and supported by the pathology report.
The technology exists to stop lab billing errors. If your current billing partner is not using it, they are not managing your revenue. They are managing your decline.
Frequently Asked Questions